Role of Glutathione in Cancer: From Mechanisms to Therapies
Open accessThe DOI matches its Crossref record; 177 of the 179 references it cites were found in a registry or an index.
Abstract
Glutathione (GSH) is the most abundant non-protein thiol present at millimolar concentrations in mammalian tissues. As an important intracellular antioxidant, it acts as a regulator of cellular redox state protecting cells from damage caused by lipid peroxides, reactive oxygen and nitrogen species, and xenobiotics. Recent studies have highlighted the importance of GSH in key signal transduction reactions as a controller of cell differentiation, proliferation, apoptosis, ferroptosis and immune function. Molecular changes in the GSH antioxidant system and disturbances in GSH homeostasis have been implicated in tumor initiation, progression, and treatment response. Hence, GSH has both protective and pathogenic roles. Although in healthy cells it is crucial for the removal and detoxification of carcinogens, elevated GSH levels in tumor cells are associated with tumor progression and increased resistance to chemotherapeutic drugs. Recently, several novel therapies have been developed to target the GSH antioxidant system in tumors as a means for increased response and decreased drug resistance. In this comprehensive review we explore mechanisms of GSH functionalities and different therapeutic approaches that either target GSH directly, indirectly or use GSH-based prodrugs. Consideration is also given to the computational methods used to describe GSH related processes for in silico testing of treatment effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Glutathione has a number of critical roles in healthy and tumor cells, in both cases supporting cell metabolism and survival. Several glutathione functionalities are directly or indirectly regulated by oncogenes (icons based on database [50]). Refer to text for further details.](https://figures.cochat.ai/paper-figures/2d404abae89748689c9cb3c19e9fd442/role-of-glutathione-in-cancer-from-mechanisms-to-therapies-figure-4.jpg)

![Figure 6 Relative GSH and GSSG concentrations vary slightly across cancer cell lines (data presented by Li et al., [65] and obtained from https://portals.broadinstitute.org/ccle). Figure shows concentration of GSSG as a function of the concentration of GSH in the same cell line (concentrations shown in mM). Insert plot shows differences in the ratio of GSH/GSSG across 928 cell lines.](https://figures.cochat.ai/paper-figures/6fff8e4943464a249286415d7f1c507d/role-of-glutathione-in-cancer-from-mechanisms-to-therapies-figure-6.jpg)
![Figure 7 Induction of metabolic reprogramming in recipient cells by internalization of producer cell-derived exosomes. Producer cells (e.g., cancer-associated fibroblasts) contain high levels of tricarboxylic acid (TCA) cycle metabolites, amino acids and lipids that can fuel the metabolic activity of recipient tumor cells contributing to tumor progression. Producer cells (e.g., glioma cells) derived exosomes can also harbor mRNA encoding ribosomal, oxidative phosphorylation and glycolytic proteins that can reprogram glycolysis and oxidative phosphorylation in recipient cells resulting in oncogenic reprogramming and transformation. Intraexosomal cargoes, such as metabolites, amino acids and mRNA are based on the studies of Cuperlovic-Culf et al., [156] Zhao et al., [149] and Zheng et al., [150]. EV, extracellular vesicles, such as exosomes; MVB, multivesicular body; OXPHOS, oxidative phosphorylation. Refer to text for more details.](https://figures.cochat.ai/paper-figures/dc3a5462e10e4f198bbce754fbce7225/role-of-glutathione-in-cancer-from-mechanisms-to-therapies-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713 · cited 2×
“It has emerged as a central regulator of a recently discovered form of cell death known as ferroptosis which is induced by cytosolic and lipid ROS [83].”
BackgroundBiogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Sies, H., & Jones, D. P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0230-3 · Cited by 5,335 · cited 15×
“The itochondrial inner membrane nicotinamide nucleotide transhydrogenase (NNT) also produces NADPH and this serves to couple reductive stress-induced H2O2 production to NT-associated NADPH and glutathione redox mechanisms [17].”
BackgroundInfluentialTumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 1×
“Chronic infection, injury and inflammation have long been recognized as risk factors for the development and progression of various human cancers [101].”
BackgroundFerroptosis: past, present and future
Li, J., Cao, F., Yin, H.-L., Huang, Z.-J., Lin, Z.-T., Mao, N., Sun, B., & Wang, G. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2298-2 · Cited by 4,171
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979 · cited 1×
“This pathway is of particular relevance to disease as oxidative stress is a hallmark of many cancers, neurodegenerative disease, and more; one result of this stress being lipid oxidation [81].”
BackgroundInflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806 · cited 2×
“A detailed review of many roles of the inflammation-driven changes in tumorigenesis has been recently provided [102].”
BackgroundMelanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · cited 1×
“Indeed the upregulation of NRF2 (nuclear factor, erythroid-derived 2-like 2 factor) has been observed in a wide array of tumors including breast, ovarian, prostate, skin, lung and pancreas [32,44].”
BackgroundCommunication by Extracellular Vesicles: Where We Are and Where We Need to Go
Tkach, M., & Théry, C. (2016) · Cell · doi:10.1016/j.cell.2016.01.043 · Cited by 3,444
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · cited 2×
“Moreover, NADPH production by the oxidative branch of the PPP is increased in many types of cancer cells [32,53].”
BackgroundMetabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740
Lu, S. C. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.008 · Cited by 2,166
Protein S-nitrosylation: Purview and parameters
Hess, D. T., Matsumoto, A., Kim, S.-O., Marshall, H. E., & Stamler, J. S. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1569 · Cited by 2,153
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 1×
“Tumor hypoxia is well known to drive higher ROS production [34].”
BackgroundThe biology and function of exosomes in cancer
Kalluri, R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81135 · Cited by 1,849
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742 · cited 1×
“The higher levels of ROS can also be caused by oncogenes such as constitutively active isoforms of RAS, and oncogenic K-RAS have been found to be necessary for precancerous lesions in the pancreas and for lung adenocarcinoma formation [35,36].”
BackgroundKorshunov, S. S., Skulachev, V. P., & Starkov, A. A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01159-9 · Cited by 1,727 · cited 1×
“It has long been known that a mild depolarization of the mitochondrial inner membrane inhibits mitochondrial ROS production [7].”
BackgroundMicroenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells
Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., Coscia, C., Iessi, E., Logozzi, M., Molinari, A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041152 · Cited by 1,555
Seiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.005 · Cited by 1,470
Dolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444 · cited 1×
“For instance, impaired Complex I function associated with ND6 mutations leads to high levels of ROS generation and a highly metastatic phenotype that can be prevented by ROS scavengers [37].”
BackgroundThe role of glutathione-S-transferase in anti-cancer drug resistance
Townsend, D. M., & Tew, K. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206940 · Cited by 1,353 · cited 1×
“The mechanism by which this detoxification occurs is through the addition of GSH to the harmful compounds via a reaction at an electrophilic residue and the sulfhydryl residue of GSH [90].”
BackgroundOxidative stress inhibits distant metastasis by human melanoma cells
Piskounova, E., Agathocleous, M., Murphy, M. M., Hu, Z., Huddlestun, S. E., Zhao, Z., Leitch, A. M., Johnson, T. M., DeBerardinis, R. J., & Morrison, S. J. (2015) · Nature · doi:10.1038/nature15726 · Cited by 1,269 · cited 1×
“This may be related to the findings that high levels of ROS can mitigate metastasis and tumorigenesis, for example in cancer cells detaching from the extracellular matrix [42,43].”
BackgroundThe role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
Glutathione metabolism in cancer progression and treatment resistance
Bansal, A., & Simon, M. C. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201804161 · Cited by 1,233
The Acidic Tumor Microenvironment as a Driver of Cancer
Boedtkjer, E., & Pedersen, S. F. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034627 · Cited by 1,223
Role of Glutathione in Cancer Progression and Chemoresistance
Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/972913 · Cited by 1,208 · cited 1×
“It is well-known that shifts in GSH metabolism often accompany tumor development, potentially as a way for the cancer cells to mitigate the impact of increased oxidative stress that results from their extraordinary metabolic rates [59].”
BackgroundMembrane transport of hydrogen peroxide
Bienert, G. P., Schjoerring, J. K., & Jahn, T. P. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.015 · Cited by 1,075 · cited 1×
“1 us) [1,2], and can traverse membranes, making it capable of functioning as a signaling molecule.”
BackgroundBrand, M. D. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.001 · Cited by 1,063
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031 · cited 1×
“This may be related to the findings that high levels of ROS can mitigate metastasis and tumorigenesis, for example in cancer cells detaching from the extracellular matrix [42,43].”
BackgroundThe hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
Harris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993 · cited 2×
“Through its many physiological functions (Figure 4) glutathione has a major role in tumors with a number of publications showing that increased cellular levels of glutathione are necessary for tumor initiation and proliferation [48,49].”
BackgroundProtein oxidation and peroxidation
Davies, M. J. (2016) · Biochemical Journal · doi:10.1042/bj20151227 · Cited by 952
Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism
Zhao, H., Yang, L., Baddour, J., Achreja, A., Bernard, V., Moss, T., Marini, J. C., Tudawe, T., Seviour, E. G., San Lucas, F. A., et al. (2016) · eLife · doi:10.7554/elife.10250 · Cited by 927
Glutathione-Associated Enzymes In Anticancer Drug Resistance
Tew, K. D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3143 · Cited by 856
ROS-dependent signal transduction
Reczek, C. R., & Chandel, N. S. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.09.010 · Cited by 849 · cited 1×
“All of these can modify the structure and activity of proteins [11].”
BackgroundHydrogen peroxide as second messenger in lymphocyte activation
Reth, M. (2002) · Nature Immunology · doi:10.1038/ni1202-1129 · Cited by 779 · cited 1×
“1 us) [1,2], and can traverse membranes, making it capable of functioning as a signaling molecule.”
BackgroundTumor-Derived Exosomes and Their Role in Cancer Progression
(2016) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2015.12.005 · Cited by 755
The interaction between ferroptosis and lipid metabolism in cancer
Li, D., & Li, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00216-5 · Cited by 703
Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677 · cited 1×
“The reversible glutathionylation/deglutathionylation reactions catalyzed by the glutaredoxin (GRX) enzymes also directly use GSH [13,14].”
BackgroundCurrent trends and challenges in cancer management and therapy using designer nanomaterials
Navya, P. N., Kaphle, A., Srinivas, S. P., Bhargava, S. K., Rotello, V. M., & Daima, H. K. (2019) · Nano Convergence · doi:10.1186/s40580-019-0193-2 · Cited by 672
Astrocytes and Glioblastoma cells release exosomes carrying mtDNA
Guescini, M., Genedani, S., Stocchi, V., & Agnati, L. F. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0288-8 · Cited by 661
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Romero, R., Sayin, V. I., Davidson, S. M., Bauer, M. R., Singh, S. X., LeBoeuf, S. E., Karakousi, T. R., Ellis, D. C., Bhutkar, A., Sánchez-Rivera, F. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4407 · Cited by 652 · cited 1×
“In tumors associated with mutated KEAP1 there is increased NRF2 and flux of glutamine to glutamate for GSH synthesis [51,52].”
BackgroundDirect Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.029 · Cited by 638
Allocati, N., Masulli, M., Di Ilio, C., & Federici, L. (2018) · Oncogenesis · doi:10.1038/s41389-017-0025-3 · Cited by 625
Glutathione peroxidase family – an evolutionary overview
Margis, R., Dunand, C., Teixeira, F. K., & Margis‐Pinheiro, M. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06542.x · Cited by 610
Glutathione levels in human tumors
Gamcsik, M. P., Kasibhatla, M. S., Teeter, S. D., & Colvin, O. M. (2012) · Biomarkers · doi:10.3109/1354750x.2012.715672 · Cited by 600 · cited 3×
“Surprisingly however, tumors in the brain and liver seem to not need this added antioxidant defense, as suggested by their markedly low levels of GSH [47].”
BackgroundInfluentialThioredoxin and thioredoxin reductase: Current research with special reference to human disease
Holmgren, A., & Lu, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.083 · Cited by 574 · cited 3×
“Beyond acting as a cofactor for GR, NADPH is also essential for the activity of thioredoxin (TRX) and peroxiredoxin (PRX) [18,19].”
BackgroundCramer, S. L., Saha, A., Liu, J., Tadi, S., Tiziani, S., Yan, W., Triplett, K., Lamb, C., Alters, S. E., Rowlinson, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4232 · Cited by 538 · cited 1×
“Through its many physiological functions (Figure 4) glutathione has a major role in tumors with a number of publications showing that increased cellular levels of glutathione are necessary for tumor initiation and proliferation [48,49].”
BackgroundUncoupling proteins and the control of mitochondrial reactive oxygen species production
Mailloux, R. J., & Harper, M.-E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.022 · Cited by 537
Self-citationBRENDA, enzyme data and metabolic information
Schomburg, I. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.47 · Cited by 525
The landscape of cancer cell line metabolism
Li, H., Ning, S., Ghandi, M., Kryukov, G. V., Gopal, S., Deik, A., Souza, A., Pierce, K., Keskula, P., Hernandez, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0404-8 · Cited by 525 · cited 6×
“GSH and GSSG values and the ratio GSH/GSSG provided by [65] are shown in Figure 6.”
BackgroundMethodInfluentialZaman, G. J., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P., Baas, F., & Borst, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7690 · Cited by 498 · cited 1×
“Early studies found that MRP1 could provide tumor cells with multidrug resistance (MDR) by exporting xenobiotics, and that this function was associated with GSH [68].”
BackgroundTGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
Oshimori, N., Oristian, D., & Fuchs, E. (2015) · Cell · doi:10.1016/j.cell.2015.01.043 · Cited by 471 · cited 3×
“Furthermore, within squamous cell carcinoma there is a dramatic increase in the expression of many enzymes of the glutathione metabolic pathway related to its antioxidant function and synthesis [61].”
BackgroundMetabolite concentrations, fluxes and free energies imply efficient enzyme usage
Park, J. O., Rubin, S. A., Xu, Y.-F., Amador-Noguez, D., Fan, J., Shlomi, T., & Rabinowitz, J. D. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2077 · Cited by 453 · cited 1×
“Additionally, GSH is not only the most prominent non-protein thiol in cells, it is also one of the most abundant metabolites, which further illustrates the demand for transport [66].”
BackgroundGlutathione transferases, regulators of cellular metabolism and physiology
Board, P. G., & Menon, D. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.019 · Cited by 446 · cited 1×
“GSH is directly used in glutathione-S-transferase (GST) reactions in the detoxification of xenobiotics or products of oxidative stress [12].”
MethodRobinson, J. L., Kocabaş, P., Wang, H., Cholley, P.-E., Cook, D., Nilsson, A., Anton, M., Ferreira, R., Domenzain, I., Billa, V., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz1482 · Cited by 442
Franklin, C. C., Backos, D. S., Mohar, I., White, C. C., Forman, H. J., & Kavanagh, T. J. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.009 · Cited by 438 · cited 2×
“pathway that creates a linkage between glutamate and cysteine via the γ-carboxyl residue of the latter to produce γ-glutamylcysteine [56].”
BackgroundATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.
Jedlitschky, G., Leier, I., Buchholz, U., M Center, & KEPPLER, D. O. R. (1994) · PubMed · Cited by 426
Extracellular vesicles: emerging targets for cancer therapy
Vader, P., Breakefield, X. O., & Wood, M. J. A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.03.002 · Cited by 421
Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
Li, I., & Nabet, B. Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0975-5 · Cited by 416
Sato, M., Kusumi, R., Hamashima, S., Kobayashi, S., Sasaki, S., Komiyama, Y., Izumikawa, T., Conrad, M., Bannai, S., & Sato, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-19213-4 · Cited by 403
A Review of Cell-Based Computational Modeling in Cancer Biology
Metzcar, J., Wang, Y., Heiland, R., & Macklin, P. (2019) · JCO Clinical Cancer Informatics · doi:10.1200/cci.18.00069 · Cited by 386
Regulation by S-Nitrosylation of Protein Post-translational Modification
Hess, D. T., & Stamler, J. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.285742 · Cited by 385 · cited 3×
“Similar to other redox signaling mechanisms such as phosphorylation, acetylation and ubiquitylation, S-nitrosation has emerged as an important redox-based post-translational modification of proteins [26,28].”
BackgroundIL‐1 and IL‐1 regulatory pathways in cancer progression and therapy
Mantovani, A., Barajon, I., & Garlanda, C. (2018) · Immunological Reviews · doi:10.1111/imr.12614 · Cited by 376
Salzano, S., Checconi, P., Hanschmann, E.-M., Lillig, C. H., Bowler, L. D., Chan, P., Vaudry, D., Mengozzi, M., Coppo, L., Sacre, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401712111 · Cited by 366
Superoxide as an intracellular radical sink
Winterbourn, C. C. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90512-s · Cited by 365
Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
Esteller, M., Corn, P. G., Ureña, J. M., Gabrielson, E. W., Baylin, S. B., & Herman, J. G. (1998) · PubMed · Cited by 356
Metabolic Reprogramming in Glioma
Strickland, M., & Stoll, E. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00043 · Cited by 345
Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology
Ballatori, N., Krance, S. M., Marchan, R., & Hammond, C. L. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.004 · Cited by 318 · cited 2×
“Furthermore, recently 8 other members of this family (MRP29) have been discovered, each with evidence to support GSH conjugates, and other GSH species, as substrates [70].”
BackgroundGlutathione peroxidases in different stages of carcinogenesis
Brigelius-Flohé, R., & Kipp, A. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.006 · Cited by 305
Unearthing the secrets of mitochondrial ROS and glutathione in bioenergetics
Mailloux, R. J., McBride, S. L., & Harper, M.-E. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.09.001 · Cited by 302
Self-citationBcl-2 expression causes redistribution of glutathione to the nucleus
Voehringer, D. W., McConkey, D. J., McDonnell, T. J., Brisbay, S., & Meyn, R. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2956 · Cited by 301 · cited 1×
“There has been some support for the idea that Bcl-2 along with the 2-oxoglutarate carrier function as GSH transporters, based on correlations between Bcl-2 expression and nuclear GSH levels in cancer, however, this idea has been abandoned since the 2-oxoglutarate carrier has been refuted as a GSH transporter [76,78].”
BackgroundOxidative stress and lipotoxicity
Hauck, A. K., & Bernlohr, D. A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066597 · Cited by 298
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
Grant, C., Rahman, F., Piekarz, R., Peer, C., Frye, R., Robey, R. W., Gardner, E. R., Figg, W. D., & Bates, S. E. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.88 · Cited by 291
Krajka-Kuźniak, V., Paluszczak, J., & Baer-Dubowska, W. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2016.12.011 · Cited by 288 · cited 2×
“transcription factor regulating expression of several enzymes responsible for glutathione synthesis, including glutamate-cysteine ligase modifier subunit (GCLM) and the glutamate-cysteine catalytic subunit (GCLC), as well as enzymes related to GSH utilization, such as glutathione reductase, glutathione peroxidase and…”
BackgroundROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications
Moldogazieva, N. T., Mokhosoev, I. M., Feldman, N. B., & Lutsenko, S. V. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1457217 · Cited by 288
Cell to Cell Signalling via Exosomes Through esRNA
Lotvall, J., & Valadi, H. (2007) · Cell Adhesion & Migration · doi:10.4161/cam.1.3.5114 · Cited by 283
Ferroptosis and Its Potential Role in Human Diseases
Han, C., Liu, Y., Dai, R., Ismail, N., Su, W., & Li, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00239 · Cited by 273 · cited 1×
“Several recent reviews have described in some detail current understanding of ferroptosis and role of GSH in this process [84,85].”
BackgroundLiou, G.-Y., Döppler, H., DelGiorno, K. E., Zhang, L., Leitges, M., Crawford, H. C., Murphy, M. P., & Storz, P. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.029 · Cited by 270 · cited 1×
“The higher levels of ROS can also be caused by oncogenes such as constitutively active isoforms of RAS, and oncogenic K-RAS have been found to be necessary for precancerous lesions in the pancreas and for lung adenocarcinoma formation [35,36].”
BackgroundThe glutathione cycle: Glutathione metabolism beyond the γ‐glutamyl cycle
Bachhawat, A. K., & Yadav, S. (2018) · IUBMB Life · doi:10.1002/iub.1756 · Cited by 270 · cited 2×
“These changes in GSH content seen in cancerous cells have been suggested as essential for the tumor’s development, and drug resistance [54,58].”
BackgroundLu, H., Samanta, D., Xiang, L., Zhang, H., Hu, H., Chen, I., Bullen, J. W., & Semenza, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513433112 · Cited by 269
Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy
Ling, X., Tu, J., Wang, J., Shajii, A., Kong, N., Feng, C., Zhang, Y., Yu, M., Xie, T., Bharwani, Z., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b06400 · Cited by 263
Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
Lien, E. C., Lyssiotis, C. A., Juvekar, A., Hu, H., Asara, J. M., Cantley, L. C., & Toker, A. (2016) · Nature Cell Biology · doi:10.1038/ncb3341 · Cited by 249 · cited 1×
“In tumors associated with mutated KEAP1 there is increased NRF2 and flux of glutamine to glutamate for GSH synthesis [51,52].”
BackgroundExtracellular Glutathione Peroxidase GPx3 and Its Role in Cancer
Chang, C., Worley, B. L., Phaëton, R., & Hempel, N. (2020) · Cancers · doi:10.3390/cancers12082197 · Cited by 226
Oncogenic pathways and the electron transport chain: a dangeROS liaison
Raimondi, V., Ciccarese, F., & Ciminale, V. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0651-y · Cited by 220 · cited 1×
“Low to medium levels of ROS can lead to genetic instability and tumor suppression (see recent reviews of [32,33]).”
BackgroundThe multifaceted role of glutathione S-transferases in cancer
Chatterjee, A., & Gupta, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.028 · Cited by 215 · cited 1×
“Interestingly, in tumorigenesis these enzymes protect from cancer development but once this fails GSTs are essential for ensuring the survival of tumor cells [91].”
BackgroundMolecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism
Somasundaram, V., Basudhar, D., Bharadwaj, G., No, J. H., Ridnour, L. A., Cheng, R. Y. S., Fujita, M., Thomas, D. D., Anderson, S. K., McVicar, D. W., et al. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7527 · Cited by 213
Chen, D., Zhang, G., Li, R., Guan, M., Wang, X., Zou, T., Zhang, Y., Wang, C., Shu, C., Hong, H., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b12025 · Cited by 211
Role of Exosomes in Crosstalk Between Cancer-Associated Fibroblasts and Cancer Cells
Yang, X., Li, Y., Zou, L., & Zhu, Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00356 · Cited by 205
Regulation of Lung Cancer Cell Migration and Invasion by Reactive Oxygen Species and Caveolin-1
Luanpitpong, S., Talbott, S. J., Rojanasakul, Y., Nimmannit, U., Pongrakhananon, V., Wang, L., & Chanvorachote, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.124958 · Cited by 201
The role of peroxiredoxins in cancer
Nicolussi, A., D'Inzeo, S., Capalbo, C., Giannini, G., & Coppa, A. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1129 · Cited by 200
Glutathione Is Recruited into the Nucleus in Early Phases of Cell Proliferation
Markovic, J., Borrás, C., Ortega, Á., Sastre, J., Viña, J., & Pallardó, F. V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609582200 · Cited by 195 · cited 1×
“Indeed, the antioxidant plays an important role within the nucleus and in cell proliferation [75,76].”
BackgroundTumor Suppressor Function of the Plasma Glutathione Peroxidase Gpx3 in Colitis-Associated Carcinoma
Barrett, C. W., Ning, W., Chen, X., Smith, J. J., Washington, M. K., Hill, K. E., Coburn, L. A., Peek, R. M., Chaturvedi, R., Wilson, K. T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3150 · Cited by 195
Activation of Glutathione Peroxidase 4 as a Novel Anti-inflammatory Strategy
Li, C., Deng, X., Xie, X., Liu, Y., Friedmann Angeli, J. P., & Lai, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01120 · Cited by 183
Regulation of redox balance in cancer and T cells
Kong, H., & Chandel, N. S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000257 · Cited by 180 · cited 3×
“Moreover, NADPH production by the oxidative branch of the PPP is increased in many types of cancer cells [32,53].”
BackgroundKojer, K., Bien, M., Gangel, H., Morgan, B., Dick, T. P., & Riemer, J. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.165 · Cited by 179 · cited 2×
“The influx of GSH into mitochondria requires passing through both the outer and inner mitochondrial membranes (OMM and IMM, respectively), however movement across the OMM is kept in equilibrium with the cytosol for small molecules such as GSH via free movement of small molecules (<5 kDa) through porin proteins in the…”
BackgroundA mathematical model of glutathione metabolism
Reed, M. C., Thomas, R. L., Pavisic, J., James, S. J., Ulrich, C. M., & Nijhout, H. F. (2008) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-5-8 · Cited by 174
Cichon, M. A., & Radisky, D. C. (2014) · Oncotarget · doi:10.18632/oncotarget.1940 · Cited by 174
Toxicity of Glutathione-Binding Metals: A Review of Targets and Mechanisms
Rubino, F. (2015) · Toxics · doi:10.3390/toxics3010020 · Cited by 173 · cited 2×
“Along with protecting against their downstream effects via GPX4, GSH is capable of directly conjugating many of these metals/metal complexes to neutralize them [82].”
BackgroundAn evolving understanding of the S-glutathionylation cycle in pathways of redox regulation
Zhang, J., Ye, Z.-W., Singh, S., Townsend, D. M., & Tew, K. D. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.038 · Cited by 172
Vyssokikh, M. Y., Holtze, S., Averina, O. A., Lyamzaev, K. G., Panteleeva, A. A., Marey, M. V., Zinovkin, R. A., Severin, F. F., Skulachev, M. V., Fasel, N., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916414117 · Cited by 164 · cited 3×
“GPX1 and 2 are highly expressed in the gastrointestinal epithelium and have been implicated in the development and promotion of colorectal cancer [8].”
BackgroundInfluentialMachine Learning Methods for Analysis of Metabolic Data and Metabolic Pathway Modeling
Cuperlovic-Culf, M. (2018) · Metabolites · doi:10.3390/metabo8010004 · Cited by 163
Sharma, L. K., Fang, H., Liu, J., Vartak, R., Deng, J., & Bai, Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr395 · Cited by 157 · cited 1×
“As well, an increased tumorigenic potential is associated with a heteroplasmic ND5 mutation that results in apoptosis resistance and increased activity of the PI3K/Akt pathway [38].”
BackgroundExtracellular Vesicles in Glioblastoma Tumor Microenvironment
Yekula, A., Yekula, A., Muralidharan, K., Kang, K., Carter, B. S., & Balaj, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03137 · Cited by 148
Extracellular acidity and increased exosome release as key phenotypes of malignant tumors
Logozzi, M., Spugnini, E. P., Mizzoni, D., Raimo, R. D., & Fais, S. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09783-8 · Cited by 144
Ortmayr, K., Dubuis, S., & Zampieri, M. (2019) · Nature Communications · doi:10.1038/s41467-019-09695-9 · Cited by 142 · cited 2×
“iversity in etabolic t i observed even in tumor cells with similar genetic background or tissue of origin [63,64].”
BackgroundSwitzer, C. H., Glynn, S. A., Cheng, R. Y.-S., Ridnour, L. A., Green, J. E., Ambs, S., & Wink, D. A. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0124 · Cited by 141
García‐Giménez, J. L., Marković, J., Dasí, F., Queval, G., Schnaubelt, D., Foyer, C. H., & Pallardó, F. V. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.005 · Cited by 139 · cited 3×
“Indeed, the antioxidant plays an important role within the nucleus and in cell proliferation [75,76].”
BackgroundJeong, E. M., Yoon, J., Lim, J., Shin, J., Cho, A. Y., Heo, J., Lee, K. B., Lee, J.-H., Lee, W. J., Kim, H.-J., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.007 · Cited by 138 · cited 4×
“The targets of GST facilitated detoxification range from the apoptosis signaling molecule 4-hydroxynonenal, to various insecticides and anti-cancer drugs like cisplatin [67,89].”
BackgroundInfluentialGlutathione: subcellular distribution and membrane transport
Oestreicher, J., & Morgan, B. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0189 · Cited by 137 · cited 1×
“Mitochondria, for example, contain 10–15% of the total cellular GSH content [72], where the OXPHOS-mediated generation of ROS results in a large demand for GSH.”
BackgroundThe self-inhibitory nature of metabolic networks and its alleviation through compartmentalization
Alam, M. T., Olin-Sandoval, V., Stincone, A., Keller, M. A., Zelezniak, A., Luisi, B. F., & Ralser, M. (2017) · Nature Communications · doi:10.1038/ncomms16018 · Cited by 135
Maiorino, M., Scapin, M., Ursini, F., Biasolo, M., Bosello, V., & Flohé, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305327200 · Cited by 127
Genome scale metabolic modeling of cancer
Nilsson, A., & Nielsen, J. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.10.022 · Cited by 127
Overcoming Glutathione S -Transferase P1–Related Cisplatin Resistance in Osteosarcoma
Pasello, M., Michelacci, F., Scionti, I., Hattinger, C. M., Zuntini, M., Caccuri, A. M., Scotlandi, K., Picci, P., & Serra, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5840 · Cited by 125 · cited 1×
“The targets of GST facilitated detoxification range from the apoptosis signaling molecule 4-hydroxynonenal, to various insecticides and anti-cancer drugs like cisplatin [67,89].”
BackgroundSilva, M. M., Rocha, C. R. R., Kinker, G. S., Pelegrini, A. L., & Menck, C. F. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-54065-6 · Cited by 120 · cited 2×
“transcription factor regulating expression of several enzymes responsible for glutathione synthesis, including glutamate-cysteine ligase modifier subunit (GCLM) and the glutamate-cysteine catalytic subunit (GCLC), as well as enzymes related to GSH utilization, such as glutathione reductase, glutathione peroxidase and…”
BackgroundEndoplasmic Reticulum Transport of Glutathione by Sec61 Is Regulated by Ero1 and Bip
Ponsero, A. J., Igbaria, A., Darch, M. A., Miled, S., Outten, C. E., Winther, J. R., Palais, G., D’Autréaux, B., Delaunay-Moisan, A., & Toledano, M. B. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.08.012 · Cited by 118 · cited 1×
“The channel protein Sec61 has been demonstrated to import and export ER GSH, and transport is modulated by Bip and Ero1 [79].”
BackgroundEstrogen-related receptors are targetable ROS sensors
Vernier, M., Dufour, C. R., McGuirk, S., Scholtes, C., Li, X., Bourmeau, G., Kuasne, H., Park, M., St‐Pierre, J., Audet‐Walsh, É., et al. (2020) · Genes & Development · doi:10.1101/gad.330746.119 · Cited by 117 · cited 2×
“Specifically, it was demonstrated that ERRs control glutamine utilization and glutathione antioxidant production [54].”
BackgroundLitmanovich, A., Khazim, K., & Cohen, I. (2018) · Oncology and Therapy · doi:10.1007/s40487-018-0089-z · Cited by 116
Mailloux, R. J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101472 · Cited by 115
Scirè, A., Cianfruglia, L., Minnelli, C., Bartolini, D., Torquato, P., Principato, G., Galli, F., & Armeni, T. (2019) · BioFactors · doi:10.1002/biof.1476 · Cited by 113
Tumor-derived exosomes: A message delivery system for tumor progression
Atay, S., & Godwin, A. K. (2014) · Communicative & Integrative Biology · doi:10.4161/cib.28231 · Cited by 110
Iommarini, L., Kurelac, I., Capristo, M., Calvaruso, M. A., Giorgio, V., Bergamini, C., Ghelli, A., Nanni, P., De Giovanni, C., Carelli, V., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt533 · Cited by 102 · cited 1×
“rewiring mitochondrial metabolism, and the antitumorigenic effect of ROS signaling is lost [39].”
BackgroundModelling changes in glutathione homeostasis as a function of quinone redox metabolism
Kelly, R. A., Leedale, J., Calleja, D., Enoch, S. J., Harrell, A., Chadwick, A. E., & Webb, S. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-42799-2 · Cited by 101
The glutathione transferase kappa family
Morel, F., & Aninat, C. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.556122 · Cited by 100 · cited 1×
“These enzymes are broadly separated into three classes based on their cellular location: cytosolic GSTs, mitochondrial GST, and microsomal GSTs (also known as MAPEG GSTs) [87].”
BackgroundJanus-Faced Tumor Microenvironment and Redox
Khramtsov, V. V., & Gillies, R. J. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5864 · Cited by 100
Glutathione peroxidases as oncotargets
Jiao, Y., Wang, Y., Guo, S., & Wang, G. (2017) · Oncotarget · doi:10.18632/oncotarget.20278 · Cited by 100
NADPH: new oxygen for the ROS theory of aging
Fernandez-Marcos, P. J., & Nóbrega-Pereira, S. (2016) · Oncotarget · doi:10.18632/oncotarget.10744 · Cited by 96
Diotallevi, M., Checconi, P., Palamara, A. T., Celestino, I., Coppo, L., Holmgren, A., Abbas, K., Peyrot, F., Mengozzi, M., & Ghezzi, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01239 · Cited by 96
Glutathione S-transferase π: a potential role in antitumor therapy
Dong, S., Sha, H., Xu, X., Hu, T.-M., Lou, R., Li, H., Wu, J.-Z., Chen, D., & Feng, J. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s169833 · Cited by 87 · cited 2×
“Along with this, the signaling role in the MAPK pathway adds to the sensitivity of the cell to excessive damage or mutation, leading to apoptosis [88].”
BackgroundFunctional Roles for Exosomal MicroRNAs in the Tumour Microenvironment
Bell, E., & Taylor, M. A. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.10.005 · Cited by 83
Identifying and targeting cancer-specific metabolism with network-based drug target prediction
Pacheco, M. P., Bintener, T., Ternes, D., Kulms, D., Haan, S., Letellier, E., & Sauter, T. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.046 · Cited by 83
Zhang, Y., Sun, C., Xiao, G., Shan, H., Tang, L., Yi, Y., Yu, W., & Gu, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1561-x · Cited by 78
1H NMR Metabolomics Analysis of Glioblastoma Subtypes
Čuperlović‐Culf, M., Ferguson, D., Culf, A. S., Morin, P., & Touaibia, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337196 · Cited by 75 · cited 2×
“iversity in etabolic t i observed even in tumor cells with similar genetic background or tissue of origin [63,64].”
BackgroundEmerging roles of the tumor-associated stroma in promoting tumor metastasis
Horimoto, Y., Polanska, U. M., Takahashi, Y., & Orimo, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20631 · Cited by 74
Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer
Roy, M., & Finley, S. D. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00217 · Cited by 74
Glutaredoxin-2 Is Required to Control Proton Leak through Uncoupling Protein-3
Mailloux, R. J., Xuan, J. Y., Beauchamp, B., Jui, L., Lou, M. F., & Harper, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442905 · Cited by 71
Self-citationMarkedly enhanced colon tumorigenesis in Apc Min mice lacking glutathione S-transferase Pi
Ritchie, K. J., Walsh, S. V., Sansom, O. J., Henderson, C. J., & Wolf, C. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911351106 · Cited by 70 · cited 1×
“For example, mice with silenced GSTp1 (also known as GST pi 1), a cytosolic GST, have a six-fold increase in colon cancer development compared to their wild-type counterparts [92].”
Glutathion s transferase π indicates chemotherapy resistance in breast cancer
Su, F., Hu, X., Jia, W., Gong, C., Song, E., & Hamar, P. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00200-2 · Cited by 66
Zeng, A., Wei, Z., Rabinovsky, R., Jun, H. J., Fatimy, R. E., Deforzh, E., Arora, R., Yao, Y., Yao, S., Yan, W., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101420 · Cited by 65
The mitochondrial dicarboxylate and 2‐oxoglutarate carriers do not transport glutathione
Booty, L. M., King, M. S., Thangaratnarajah, C., Majd, H., James, A. M., Kunji, E. R. S., & Murphy, M. P. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.01.027 · Cited by 63 · cited 1×
“Previously, two transporters had been identified to carry out this function, the dicarboxylate and the 2-oxoglutarate carriers (SLC25A10 and SLC25A11, respectively); however, this has recently been put under doubt [74].”
BackgroundKoeberle, S. C., Gollowitzer, A., Laoukili, J., Kranenburg, O., Werz, O., Koeberle, A., & Kipp, A. P. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101388 · Cited by 63
dbGSH: a database of S-glutathionylation
Chen, Y., Lu, C.-T., Lee, T.-Y., & Chen, Y. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu301 · Cited by 61
Role of glutathione in cell nucleus
Markovic, J., García-Gimenez, J. L., Gimeno, A., Viña, J., & Pallardó, F. V. (2010) · Free Radical Research · doi:10.3109/10715762.2010.485989 · Cited by 60 · cited 1×
“Experiments have reinforced this idea, disproving nuclear synthesis of GSH or passive movement across membranes [77].”
BackgroundExpression and clinical value of peroxiredoxin-1 in patients with pancreatic cancer
Cai, C.-Y., Zhai, L., Wu, Y., & Tang, Z. (2014) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2014.11.037 · Cited by 57
Choi, J.-A., Lee, J.-W., Kim, H., Kim, E.-Y., Seo, J. M., Ko, J., & Kim, J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp203 · Cited by 57
Chronicles of a reductase: Biochemistry, genetics and physio-pathological role of GSNOR
Rizza, S., & Filomeni, G. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.05.014 · Cited by 57
Glutathione-Depleting Pro-Oxidant as a Selective Anticancer Therapeutic Agent
Yoo, D., Jung, E., Noh, J., Hyun, H., Seon, S., Hong, S., Kim, D., & Lee, D. (2019) · ACS Omega · doi:10.1021/acsomega.9b00140 · Cited by 54
Nox1 causes ileocolitis in mice deficient in glutathione peroxidase-1 and -2
Esworthy, R. S., Kim, B.-W., Chow, J., Shen, B., Doroshow, J. H., & Chu, F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.018 · Cited by 53
Zhang, X. Z., Liu, P., Zhang, C., Chiewchengchol, D., Zhao, F., Yu, H., Li, J., Kambara, H., Luo, K. Y., Venkataraman, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.070 · Cited by 53
Zendehdel, K., Bahmanyar, S., McCarthy, S., Nyrén, O., Andersson, B., & Ye, W. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9399-7 · Cited by 52
Selenium-Dependent Glutathione Peroxidases During Tumor Development
Kipp, A. P. (2017) · Advances in cancer research · doi:10.1016/bs.acr.2017.07.004 · Cited by 50
Monitoring intracellular redox conditions in the endoplasmic reticulum of living yeasts
Delic, M., Mattanovich, D., & Gasser, B. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.01935.x · Cited by 49 · cited 1×
“of GSH as in the cytosol, although their redox ratio (reduced GSH to oxidized GSSG) may vary [71].”
BackgroundYoung, A., Gill, R., & Mailloux, R. J. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.12.003 · Cited by 48 · cited 1×
“The reversible glutathionylation/deglutathionylation reactions catalyzed by the glutaredoxin (GRX) enzymes also directly use GSH [13,14].”
BackgroundCysteine Glutathionylation Acts as a Redox Switch in Endothelial Cells
Lermant, A., & Murdoch, C. E. (2019) · Antioxidants · doi:10.3390/antiox8080315 · Cited by 47
Song, K., Yi, J., Shen, X., & Cai, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048924 · Cited by 46 · cited 1×
“Furthermore, polymorphisms of the various GSTs have been associated with susceptibility to many diseases including several cancers [93,94].”
BackgroundAnalysis and Simulation of Glioblastoma Cell Lines-Derived Extracellular Vesicles Metabolome
Čuperlović‐Culf, M., Khieu, N. H., Surendra, A., Hewitt, M., Charlebois, C., & Sandhu, J. K. (2020) · Metabolites · doi:10.3390/metabo10030088 · Cited by 44
Self-citationGlutathionylation of UCP2 sensitizes drug resistant leukemia cells to chemotherapeutics
Pfefferle, A., Mailloux, R. J., Adjeitey, C. N., & Harper, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.006 · Cited by 42
Self-citationBasal S -Nitrosylation Is the Guardian of Tissue Homeostasis
Furuta, S. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.003 · Cited by 41 · cited 3×
“Similar to other redox signaling mechanisms such as phosphorylation, acetylation and ubiquitylation, S-nitrosation has emerged as an important redox-based post-translational modification of proteins [26,28].”
BackgroundS-nitrosylation and its role in breast cancer angiogenesis and metastasis
Ehrenfeld, P., Cordova, F., Durán, W. N., & Sánchez, F. A. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.03.002 · Cited by 41
Metabolic reprogramming dynamics in tumor spheroids: Insights from a multicellular, multiscale model
Roy, M., & Finley, S. D. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007053 · Cited by 41
Cañas, A., Lopez-Sanchez, L. M., Peñarando, J., Valverde, A. M., Conde, F., Hernandez, V. A., Fuentes, E., López-Pedrera, C., de la Haba-Rodríguez, J., Aranda, E., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.02.005 · Cited by 39
Smith, C. D., Schmidt, C. A., Lin, C., Fisher‐Wellman, K. H., & Neufer, P. D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013899 · Cited by 37 · cited 2×
“The mitochondrial inner membrane nicotinamide nucleotide transhydrogenase (NNT) also produces NADPH and this serves to couple reductive stress-induced H2O2 production to NNT-associated NADPH and glutathione redox mechanisms [17].”
BackgroundAltered glutamate cysteine ligase expression and activity in renal cell carcinoma
Li, M., Zhang, Z., Yuan, J., Zhang, Y., & Jin, X. (2014) · Biomedical Reports · doi:10.3892/br.2014.359 · Cited by 36 · cited 1×
“Some examples of the transformed GSH metabolism in cancers can be seen in renal cell carcinoma, where there are increases in both expression and activity of GCLC and GCLM, causing elevated levels of GSH [60].”
BackgroundTomonobu, N., Komalasari, N. L. G. Y., Sumardika, I. W., Jiang, F., Chen, Y., Yamamoto, K.-I., Kinoshita, R., Murata, H., Inoue, Y., & Sakaguchi, M. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109085 · Cited by 34 · cited 1×
“Interestingly, a recent study has shown that xylitol, a compound found in the fungus Cordyceps militaris, may be a promising anticancer therapy via regulation of GSH [80].”
Background1H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism
Čuperlović‐Culf, M., Cormier, K., Touaibia, M., Reyjal, J., Robichaud, S., Belbraouet, M., & Turcotte, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29947 · Cited by 33 · cited 3×
“GPX4 is a major regulator of this form of programmed cell death, which is further exacerbated in cancers where recent studies have shown GPX4 as essential in some tumors [55,61].”
BackgroundComprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer
Mei, J., Hao, L., Liu, X., Sun, G., Xu, R., Wang, H., & Liu, C. (2019) · Biomarker Research · doi:10.1186/s40364-019-0168-9 · Cited by 33
Cheng, R. Y. S., Basudhar, D., Ridnour, L. A., Heinecke, J. L., Kesarwala, A. H., Glynn, S. A., Switzer, C., Ambs, S., Miranda, K. M., & Wink, D. A. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.08.003 · Cited by 25
Seitz (2009) · International Journal of Oncology · doi:10.3892/ijo_00000523 · Cited by 22
Song, Y., Chen, J., Liu, K., Zhou, K., Lü, Y., Wang, X., Yang, Y., & Liu, X. (2019) · Gene · doi:10.1016/j.gene.2019.144077 · Cited by 22 · cited 1×
“Recently, microenvironment GST has been suggested as important to metastasis and apoptosis in ovarian and bladder cancer [99,100].”
BackgroundImmunologic Approaches to the Classification and Management of Lymphomas and Leukemias
Bennett, J. M., & Foon, K. A. (1988) · Cancer treatment and research · doi:10.1007/978-1-4613-1713-5 · Cited by 21
Horowitz, M. P., Esakov, E. L., Rose, P. G., & Reizes, O. (2020) · Annals of Translational Medicine · doi:10.21037/atm-2019-cm-08 · Cited by 21 · cited 1×
“Recently, microenvironment GST has been suggested as important to metastasis and apoptosis in ovarian and bladder cancer [99,100].”
BackgroundKitajima, T., & Hara, K. (1991) · Biological Cybernetics · doi:10.1007/bf00224703 · Cited by 18 · cited 3×
“Beyond acting as a cofactor for GR, NADPH is also essential for the activity of thioredoxin (TRX) and peroxiredoxin (PRX) [18,19].”
BackgroundZhang, X., Liu, P., Zhang, C., Chiewchengchol, D., Zhao, F., Li, J., Venkataraman, A., Zhou, Z., Zhou, W., Yu, H., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155837 · Cited by 10
Cited by
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
Xiong, Y., Xiao, C., Li, Z., & Yang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00718h · Cited by 692
Photodynamic Therapy—Current Limitations and Novel Approaches
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.691697 · Cited by 599
A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche
Zepeda-Rivera, M., Minot, S. S., Bouzek, H., Wu, H., Blanco-Míguez, A., Manghi, P., Jones, D. S., LaCourse, K. D., Wu, Y., McMahon, E. F., et al. (2024) · Nature · doi:10.1038/s41586-024-07182-w · Cited by 451
“GSH deficiency or an elevated ratio of oxidized (GSSG) to reduced (GSH) forms of glutathione increases the vulnerability of mammalian cells to oxidative stress, inflammation and tumour progression 55 .”
BackgroundLipid Peroxidation and Antioxidant Protection
Valgimigli, L. (2023) · Biomolecules · doi:10.3390/biom13091291 · Cited by 335
“Therefore, compared to healthy non-malignant cells, cancer cells have altered redox homeostasis and higher levels of LP; in many types of tumor cells, these higher levels support their growth, proliferation and survival [81].”
Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy
Li, H., Kim, Y., Jung, H., Hyun, J. Y., & Shin, I. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00722c · Cited by 356
Metadata
- Authors
- Kennedy, L., Sandhu, J. K., Harper, M.-E., & Cuperlovic-Culf, M.
- Affiliations
- University of Ottawa (CA)
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-10-09
- Volume
- 10
- Issue
- 10
- Pages
- 1429
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7600400
- OpenAlex
- W3092136373
- Cited by
- 880
- References
- 179
- Citations by year
- 2026: 140 · 2025: 197 · 2024: 201 · 2023: 159 · 2022: 123 · 2021: 58
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- NPARC (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Council Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- glutathione, cancer, redox homeostasis, antioxidant defense, reactive oxygen species, reactive nitrogen species, lipid peroxidation, xenobiotic detoxification, chemoresistance, ferroptosis, apoptosis, tumor progression
- MeSH terms
- Animals, Drug Screening Assays, Antitumor, Glutathione, Homeostasis, Humans, Neoplasms, Oxidation-Reduction, Signal Transduction, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.